Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | GABRR1 | P24046 | 5/20 | 0.52 |
| ▸ | ACE | P12821 | 1/20 | 0.46 |
| ▸ | AKR1C3 | P42330 | 1/20 | 0.45 |
| ▸ | AKR1C1 | Q04828 | 1/20 | 0.45 |
| ▸ | PLG | P00747 | 1/20 | 0.42 |
| ▸ | PLAT | P00750 | 1/20 | 0.42 |
| ▸ | LMNA | P02545 | 1/20 | 0.42 |
| ▸ | GABRP | O00591 | 1/20 | 0.42 |
| ▸ | GABRD | O14764 | 1/20 | 0.42 |
| ▸ | GABRA1 | P14867 | 1/20 | 0.42 |
| ▸ | TSHR | P16473 | 1/20 | 0.42 |
| ▸ | GABRB1 | P18505 | 1/20 | 0.42 |
| ▸ | GABRG2 | P18507 | 1/20 | 0.42 |
| ▸ | GABRB3 | P28472 | 1/20 | 0.42 |
| ▸ | GABRA5 | P31644 | 1/20 | 0.42 |
| ▸ | GABRA3 | P34903 | 1/20 | 0.42 |
| ▸ | GABRA2 | P47869 | 1/20 | 0.42 |
| ▸ | GABRB2 | P47870 | 1/20 | 0.42 |
| ▸ | GABRA4 | P48169 | 1/20 | 0.42 |
| ▸ | GABRE | P78334 | 1/20 | 0.42 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL28799 | 1.00 | GABRR1 (0.52) | GABRR1ACEAKR1C3AKR1C1PLG | |
| SCHEMBL2019219 | 1.00 | GABRR1 (0.52) | GABRR1ACEAKR1C3AKR1C1PLG | |
| SCHEMBL9721284 | 1.00 | GABRR1 (0.52) | GABRR1ACEAKR1C3AKR1C1PLG | |
| SCHEMBL21664518 | 1.00 | GABRR1 (0.52) | GABRR1ACEAKR1C3AKR1C1PLG | |
| SCHEMBL9249263 | 1.00 | GABRR1 (0.52) | GABRR1ACEAKR1C3AKR1C1PLG | |
| Hydrochloric Acid SCHEMBL28557936 | 0.97 | GABRR1 (0.50) | GABRR1ACEAKR1C3AKR1C1PLG | |
| SCHEMBL16405082 | 0.89 | GABRR1 (0.42) | GABRR1ACEAKR1C3AKR1C1SLC1A2 | |
| SCHEMBL1963027 | 0.88 | GABRR1 (0.58) | GABRR1ACELMNAGABRPGABRD | |
| Hydrochloric Acid SCHEMBL3795818 | 0.85 | GABRR1 (0.55) | GABRR1ACEAKR1C3AKR1C1LMNA | |
| SCHEMBL21641650 | 0.85 | GABRR1 (0.44) | GABRR1ACEAKR1C3AKR1C1PLG |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 30 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-3604265-B1 | METHOD FOR PRODUCING CIS,CIS-1,2,4-CYCLOHEXANE TRICARBOXYLIC ACID CRYSTAL | MITSUBISHI GAS CHEMICAL CO (JP) | 2021-10-20 | — | — | EP | claimed |
| US-11021428-B2 | Method for producing cis,cis-1,2,4-cyclohexane tricarboxylic acid crystal | MITSUBISHI GAS CHEMICAL COMPANY, INC. (JP) | 2021-06-01 | — | — | US | claimed |
| US-20200317596-A1 | METHOD FOR PRODUCING CIS,CIS-1,2,4-CYCLOHEXANE TRICARBOXYLIC ACID CRYSTAL | MITSUBISHI GAS CHEMICAL COMPANY, INC. (JP) | 2020-10-08 | — | — | US | claimed |
| EP-3604265-A1 | METHOD FOR PRODUCING cis,cis-1,2,4-CYCLOHEXANE TRICARBOXYLIC ACID CRYSTAL | Mitsubishi Gas Chemical Company, Inc. (JP) | 2020-02-05 | — | — | EP | claimed |
| EP-2343544-B1 | Method for analyzing hemoglobin by electrophoresis | ARKRAY INC (JP) | 2015-03-11 | — | — | EP | claimed |
| US-8702941-B2 | Method of analyzing hemoglobin by electrophoresis | ARKARY, Inc. (JP) | 2014-04-22 | — | — | US | claimed |
| EP-2343544-A1 | Method for analyzing hemoglobin by electrophoresis | Arkray, Inc. (JP) | 2011-07-13 | — | — | EP | claimed |
| WO-2022264994-A1 | RESIN COMPOSITION, RESIN SHEET, MULTILAYER PRINTED WIRING BOARD, AND SEMICONDUCTOR DEVICE | 三菱瓦斯化学株式会社 | 2022-12-22 | — | — | WO | disclosed |
| EP-3604265-B1 | METHOD FOR PRODUCING CIS,CIS-1,2,4-CYCLOHEXANE TRICARBOXYLIC ACID CRYSTAL | MITSUBISHI GAS CHEMICAL CO (JP) | 2021-10-20 | — | — | EP | disclosed |
| EP-3604265-B1 | METHOD FOR PRODUCING CIS,CIS-1,2,4-CYCLOHEXANE TRICARBOXYLIC ACID CRYSTAL | MITSUBISHI GAS CHEMICAL CO (JP) | 2021-10-20 | — | — | EP | disclosed |
| US-11021428-B2 | Method for producing cis,cis-1,2,4-cyclohexane tricarboxylic acid crystal | MITSUBISHI GAS CHEMICAL COMPANY, INC. (JP) | 2021-06-01 | — | — | US | disclosed |
| US-11021428-B2 | Method for producing cis,cis-1,2,4-cyclohexane tricarboxylic acid crystal | MITSUBISHI GAS CHEMICAL COMPANY, INC. (JP) | 2021-06-01 | — | — | US | disclosed |
| US-11021428-B2 | Method for producing cis,cis-1,2,4-cyclohexane tricarboxylic acid crystal | MITSUBISHI GAS CHEMICAL COMPANY, INC. (JP) | 2021-06-01 | — | — | US | disclosed |
| US-8702941-B2 | Method of analyzing hemoglobin by electrophoresis | ARKARY, Inc. (JP) | 2014-04-22 | — | — | US | disclosed |
| EP-2343544-A1 | Method for analyzing hemoglobin by electrophoresis | Arkray, Inc. (JP) | 2011-07-13 | — | — | EP | disclosed |
| US-20110155573-A1 | METHOD OF ANALYZING HEMOGLOBIN BY ELECTROPHORESIS | ARKRAY, INC. (JP) | 2011-06-30 | — | — | US | disclosed |
| EP-1686121-B1 | LIQUID CYCLOHEXANE-TRICARBOXYLIC ACID ANHYDRIDE | MITSUBISHI GAS CHEMICAL CO (JP) | 2010-02-10 | — | — | EP | disclosed |
| US-7569708-B2 | Trans, trans-1,2,4-cyclohexanetricarboxylic acid-1,2-anhydride liquid; highly radiation transparent (color number <100 Hazen); seals for photoelectric transducers; coatings. adhesives; molding materials; plasticizers; solar cells; formed by melting 1,2,4-cyclohexanetricarboxylic acid at 180-300 degrees | MITSUBISHI GAS CHEMICAL COMPANY, INC. (JP) | 2009-08-04 | — | — | US | disclosed |
| US-20070123716-A1 | Liquid cyclohexane-tricarboxylic acid anhydride | MITSUBISHI GAS CHEMICAL COMPANY, INC. (JP) | 2007-05-31 | — | — | US | disclosed |
| EP-1686121-A1 | LIQUID CYCLOHEXANE-TRICARBOXYLIC ACID ANHYDRIDE | MITSUBISHI GAS CHEMICAL COMPANY, INC. (JP) | 2006-08-02 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-11021428-B2 | Method for producing cis,cis-1,2,4-cyclohexane tricarboxylic acid crystal | SLC16A1, CA1, RCC1 | GABRR1 3475/4885ACE 661/4885AKR1C3 144/4885 |
| US-20200317596-A1 | METHOD FOR PRODUCING CIS,CIS-1,2,4-CYCLOHEXANE TRICARBOXYLIC ACID CRYSTAL | SLC16A1, CA1, RCC1 | GABRR1 3475/4885ACE 661/4885AKR1C3 144/4885 |
| US-20070123716-A1 | Liquid cyclohexane-tricarboxylic acid anhydride | HCAR1, TECR, HCAR2 | GABRR1 761/4885ACE 1274/4885AKR1C3 186/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.